Navigation Links
Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
Date:3/17/2009

ALLEGAN, Mich., March 17 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its partner Cobrek Pharmaceuticals, Inc. has filed an Abbreviated New Drug Application (ANDA) for Clindamycin Phosphate Foam 1%, a generic version of Evoclin(R) Foam 1%. The Company believes that Cobrek is the first to file an ANDA with a Paragraph IV certification against Evoclin(R).

Evoclin(R) (clindamycin phosphate) Foam 1% is a topical antibiotic indicated for topical application in the treatment of acne vulgaris, and had sales of approximately $44 million for the 12 months ended January 2009, as measured by Wolters Kluwer Health.

The ANDA for Clindamycin Phosphate Foam, 1%, which was filed prior to enactment of the Q1 Program Supplemental Funding Act of 2008 (the "Q1 Act"), was timely amended to contain a Paragraph IV Certification in accordance with the Q1 Act. On March 13, 2009, Stiefel filed suit alleging patent infringement in the United States District Court for the District of Delaware against Perrigo and its partner Cobrek. Stiefel also has filed a Citizen Petition with the U.S. Food and Drug Administration ("the FDA") seeking to have a 30 month stay of Cobrek's ANDA approval imposed. The FDA has not ruled, neither have the courts, regarding whether the Q1 Act entitles Stiefel to a 30 month stay.

Perrigo's Chairman and CEO Joseph C. Papa concluded, "This filing reflects our continuing investment in new products. We are the manufacturer and developer of this product as well as the exclusive sales and marketer. As always, Perrigo is committed to making quality healthcare more affordable for our customers and drive value for our shareholders."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescript
'/>"/>

SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
7. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
8. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
9. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
10. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
11. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... HEIDELBERG, Germany, Dec. 2 febit...ners of the "Top 10 Innovations of 2009" by The S...ce capture technology for high-throughput sequenci...s of invention, vision and utility. ,, The Sc...uate a broad range of life science technologies an...
(Date:12/2/2009)... 2 TeamHealth Teleradiology ( www....largest provider of hospital-based clinical outsou...ovide teleradiology services for two groups in Sou...d with UpState Carolina Radiology located in Spart...to provide services for the following four hospita...
(Date:12/2/2009)... Decision Resources, one of the wor...aceutical and healthcare issues, finds that generi...antipsychotics will cause the schizophrenia drug m...2 billion in 2013 in the United States, France, Ge... ,, The new Pharmacor report entitled Schizoph...
Breaking Medicine Technology:The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2Mt Lebanon Comes Alive Saturday August 8th with ULTRAparty 52936 1Mt Lebanon Comes Alive Saturday August 8th with ULTRAparty 52936 2Mylan Reports That the FDA Determined That All Accusations Were Unfounded 52934 1Mylan Reports That the FDA Determined That All Accusations Were Unfounded 52934 2Survey Finds 64 25 of Americans Unaware Sunscreen Inhibits Vitamin D Production 52932 1Survey Finds 64 25 of Americans Unaware Sunscreen Inhibits Vitamin D Production 52932 2Survey Finds 64 25 of Americans Unaware Sunscreen Inhibits Vitamin D Production 52932 3
...June 2 Physicians affiliated with the US,Oncology...eir clinical,research at the 44th Annual Meeting o... held May 30 - June 3, 2008 in Chicago., Dr. Joyc... Sammons,Cancer Center, an affiliate of US Oncolog...ndomized Phase III trial that studied lapatanib (L...
...esults of Perifosine in the Treatment of Patients ...linemia to be presented Tomorrow, Tuesday...ne 2 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX...401,(Perifosine) have been selected for both poste... Society of Clinical Oncology Meeting,currently ta...
Other Medicine Technology:US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 4US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 5Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 4Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 5
(Date:12/2/2009)...e a prostate-specific antigen (PSA) value of less ...eam radiation therapy (EBRT) are less likely to ha...ccording to a study in the December 1 issue of the...gy*Physics, the official journal of the American S...ls in a prostate cancer patient are monitored afte...
(Date:12/2/2009)...ed movement therapy (CIMT) is a potentially effect...gic cerebral palsy, but more research is needed, a...he November issue of Physical Therapy (PTJ), the...py Association (APTA). The review, which analyzed ...concluded that further research should focus on th...
(Date:12/2/2009)... Aid has been a top name in the medical supply ind...roducts, professional staff, and a keen understand...id has established itself as a provider of ground ...rst aid supplies distributor. The distinguished hi...to its next phase with the redesign and launch of ...
(Date:12/2/2009)... Race Series to increase awareness of prostate can...rtance of early detection , ...en, families, friends and neighbors – at all... in the Rudolph Ramble 5K. The Rudolph Ramble 5K ...h was launched by the Prostate Conditions Educati...
(Date:12/2/2009)...f Kendall Hunt authors earned the 2009 Gifted Chil...National Association for Gifted Children’s a... , Dubuque, IA (PRWEB) De...arned the 2009 Gifted Child Quarterly Paper of the... Gifted Children’s annual conference in St. ...
Breaking Medicine News(10 mins):Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2
... Alternative Reproductive Resources ( ARR ) toda...parents avoid some of the pitfalls of "do-it-yours...rogate Management Services , the Chicago egg dona... not likely to be equipped to handle on their own....
...ns to reduce the spread of HIV and other sexually ...ples and ethnically diverse populations continues ...s issue, NIMH awarded a two-year grant to David Pr...ention designed for young, heterosexual Latino cou...
...ting Offline , , CINCINNATI, May 26 A new study ...enage girls present themselves online. , , The st...ows that teen girls who would depict themselves on...uals offline. , , Moreover, 40 percent of all 173...
...e judicial experience than any Supreme Court nomin..."Judge Sotomayor,s nomination to be a Supreme Cour...cans. As a Latina and a mother, I can say to my da...ispanic health advocacy group. , , Dr. Delgado s...
...m, The Netherlands and San Antonio, TX, USA John ... of the 2009 Alzheimer Award presented by the Jou... outstanding work, "Identification of miRNA change...ell et al. , "My co-authors and I are extremely ...
... , Philadelphia, Pa. (V... attend the second annual Partnerships for the Chi...hildren, as they honor and recognize Daniel J. Hil...dren throughout the Delaware Valley. , , ,Northern...
Other Medicine News:Health News:New Program Offsets Risks of 'Do-It-Yourself' Gestational Surrogacy 2Health News:HIV prevention program gets a boost from NIMH recovery act funds 2Health News:Study Demonstrates Internet Risks for Teen Girls 2Health News:Study Demonstrates Internet Risks for Teen Girls 3Health News:John P. Cogswell, Ph.D., receives 2009 Alzheimer Award 2Health News:AmeriHealth Mercy President and CEO Daniel J. Hilferty to be Honored by Northern Home for Children at its Annual Partnerships for the Children Awards Dinner 2
...ly (L-Lactic Acid) material which has a long-term ...ut the healing process. The Bio-Anchor nearly eli...s absorbed into the tissue or can easily be over-d...s for accurate placement and comes pre-threaded wi...
...oly-L-Lactide Acid (PLLA) and retains the benefits...ency and a history of clinical effectiveness and s...tion reduces various steps that are often cumberso... placed through the rotator cuff tendon and into t...
...etter. How can one of the leading soft tissue anch... use in all surgical environments; open, mini-open... Needles combines the TwinFix Suture Anchor with a... and needle delivery system. Surgeons no longer ne...
Twinfix Suture Anchors
Medicine Products: